Double blind controlled clinical trial of radiation plus razoxane (ICRF 159) versus radiation plus placebo in the treatment of head and neck cancer
- 28 February 1978
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 4 (1-2) , 115-119
- https://doi.org/10.1016/0360-3016(78)90125-6
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- ICRF 159, (±) 1,2-di(3,5-dioxopiperazin-1-yl)propane NSC-129,943; RazoxaneCancer Treatment Reviews, 1976
- The role of chemotherapy in the management of cancer of the head and neck: A reviewCancer, 1975
- The integration of chemotherapy into a combined modality approach to cancer therapy: V. Squamous cell cancer of the head and neckCancer Treatment Reviews, 1975
- Synergism of ICRF 159 and radiotherapy in treatment of experimental tumorsCancer, 1974
- Clinical use of radiation sensitizing agentsCancer Treatment Reviews, 1974
- Sequential Medical PlansBiometrics, 1952